BACKGROUND: In several countries worldwide, school-based human papillomavirus (HPV) vaccination programs have been successful; however, little research has explored US stakeholders' acceptance toward school-based HPV vaccination programs. METHODS: A total of 13 focus groups and 12 key informant interviews (N = 117; 85% females; 66% racial/ethnic minority) were conducted with 5 groups of stakeholders: parents of adolescent girls, parents of adolescent boys, adolescent girls, middle school nurses, and middle school administrators throughout the 5 public health regions of New Mexico. RESULTS: All groups of stakeholders lacked knowledge on HPV and HPV vaccines. Stakeholders were interested in--but apprehensive about--the benefits of HPV vaccination. Despite previous literature showing the benefits of using middle schools as an HPV vaccination site, stakeholders did not deem middle schools as a viable site for vaccination. Nurses reported that using the school as an HPV vaccination site had not occurred to them; parents and adolescents stated they were uncertain about using this type of program. School administrators indicated that they lacked implementation authority. CONCLUSIONS: Our study uncovered barriers to using middle schools as a site of HPV vaccination. Resources should be directed toward increased support and education for middle school nurses who function as opinion leaders relevant to the uptake of HPV vaccination.
BACKGROUND: In several countries worldwide, school-based human papillomavirus (HPV) vaccination programs have been successful; however, little research has explored US stakeholders' acceptance toward school-based HPV vaccination programs. METHODS: A total of 13 focus groups and 12 key informant interviews (N = 117; 85% females; 66% racial/ethnic minority) were conducted with 5 groups of stakeholders: parents of adolescent girls, parents of adolescent boys, adolescent girls, middle school nurses, and middle school administrators throughout the 5 public health regions of New Mexico. RESULTS: All groups of stakeholders lacked knowledge on HPV and HPV vaccines. Stakeholders were interested in--but apprehensive about--the benefits of HPV vaccination. Despite previous literature showing the benefits of using middle schools as an HPV vaccination site, stakeholders did not deem middle schools as a viable site for vaccination. Nurses reported that using the school as an HPV vaccination site had not occurred to them; parents and adolescents stated they were uncertain about using this type of program. School administrators indicated that they lacked implementation authority. CONCLUSIONS: Our study uncovered barriers to using middle schools as a site of HPV vaccination. Resources should be directed toward increased support and education for middle school nurses who function as opinion leaders relevant to the uptake of HPV vaccination.
Authors: Matthew F Daley; C Robinette Curtis; Jennifer Pyrzanowski; Jennifer Barrow; Kathryn Benton; Lisa Abrams; Steven Federico; Linda Juszczak; Paul Melinkovich; Lori A Crane; Allison Kempe Journal: J Adolesc Health Date: 2009-05-30 Impact factor: 5.012
Authors: Paul L Reiter; Brenda Stubbs; Catherine A Panozzo; Dianne Whitesell; Noel T Brewer Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-09-23 Impact factor: 4.254
Authors: Jessica A Kadis; Annie-Laurie McRee; Sami L Gottlieb; Morgan R Lee; Paul L Reiter; Patricia J Dittus; Noel T Brewer Journal: Vaccine Date: 2011-02-05 Impact factor: 3.641
Authors: Randall Starling; Don Helme; Jessica A Nodulman; Angela D Bryan; David B Buller; Robert Lewis Donohew; W Gill Woodall Journal: Calif J Health Promot Date: 2014-12
Authors: Randall Starling; Jessica A Nodulman; Alberta S Kong; Cosette M Wheeler; David B Buller; W Gill Woodall Journal: Online J Commun Media Technol Date: 2015-10
Authors: Randall Starling; Jessica A Nodulman; Alberta S Kong; Cosette M Wheeler; David B Buller; W Gill Woodall Journal: J Consum Health Internet Date: 2014-01-01
Authors: Madhura S Rane; Libby C Page; Emma McVeigh; Kaetlin Miller; David Baure; M Elizabeth Halloran; Jeffrey S Duchin Journal: Vaccine Date: 2021-02-25 Impact factor: 3.641
Authors: Peng-Jun Lu; David Yankey; Benjamin Fredua; Mei-Chuan Hung; Tanja Y Walker; Lauri E Markowitz; Laurie D Elam-Evans Journal: J Adolesc Health Date: 2021-04-16 Impact factor: 7.830